Differential virulence of Candida albicans and C. dubliniensis a role for tor1 kinase?

Virulence

Volumn 2, Issue 1, 2011, Pages 77-81

  Sullivan, Derek J ^a   Moran, Gary P ^a  

^a DUBLIN DENTAL UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Candida albicans; Candida dubliniensis; Fungal morphogenesis; Rapamycin; TOR

Indexed keywords

TARGET OF RAPAMYCIN KINASE;

ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGAL VIRULENCE; FUNGUS HYPHAE; OPPORTUNISTIC INFECTION;

CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 79951497456     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.1.15002     Document Type: Article

References (27)

1. Butler G, Rasmussen MD, Lin MF, Santos MAS, Sakthikumar S, Munro CA, et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 2009; 459:657-662.
2. Calderone RA. Candida and candidiasis. Washington D.C.: ASM Press, 2002.
3. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell 1997; 90:939-949.
4. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003; 2:1053-1060.
5. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141:1507-1521.
6. Kibbler CC, Shila Ainscough, Rosemary A. Barnes, Gransden WR, Holliman RE, Johnson EM, et al. Management and outcome of blood stream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54:18-24.
7. Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 2007; 56:1066-1075.
8. Stokes C, Moran, G.P., Spiering MJ, Cole GT, Coleman DC, et al. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol 2007; 44:920-931.
9. Vilela MM, Kamei K, Sano A, Tanaka R, Uno J, Takahashi I, et al. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Med Mycol 2002; 40:249-257.
10. Gilfillan GD, Sullivan DJ, Haynes K, Parkinson T, Coleman DC, Gow NAR. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 1998; 144:829-838.
11. Jackson AP, Gamble JA, Yeomans T, Moran GP, Saunders D, Harris D, et al. Comparative genomics of the fungal pathogens Candida dubliniensis and C. albicans. Genome Res 2009; 19:2231-2244.
12. Spiering MJ, Moran GP, Chauvel M, Maccallum DM, Higgins J, Hokamp K, et al. Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model. Eukaryot Cell 2010; 9:251-265.
13. O'Connor L, Caplice N, Coleman DC, Sullivan DJ, Moran GP. Differential filamentation of Candida albicans and C. dubliniensis is governed by nutrient regulation of UME6 expression. Eukaryot Cell 2010; 9:1383-1397.
14. Staib P, Morschhauser J. Differential expression of the NRG1 repressor controls species-specific regulation of chlamydospore development in Candida albicans and Candida dubliniensis. Mol Microbiol 2005; 55:637-652.
15. Moran GP, MacCallum DM, Spiering MJ, Coleman DC, Sullivan DJ. Differential regulation of the transcriptional repressor NRG1 accounts for altered host cell interactions in Candida albicans and Candida dubliniensis. Molecular Microbiology 2007; 66:915-929.
16. Biswas S, Roy M, Datta A. N-Acetylglucosamineinducible CaGAP1 encodes a general amino acid permease which co-ordinates external nitrogen source response and morphogenesis in Candida albicans. Microbiology 2003; 149:2597-2608.
17. Biswas K, Morschhäuser J. The Mep2p ammonium permease controls nitrogen starvation-induced filamentous growth in Candida albicans. Molecular Microbiology 2005; 56:649-669.
18. Tripathi G, Wiltshire C, Macaskill S, Tournu H, Budge S, Brown AJP. Gcn4 co-ordinates morphogenetic and metabolic responses to amino acid starvation in Candida albicans. EMBO J 2002; 21:5448-5456.
19. Banerjee M, Thompson DS, Lazzell A, Carlisle PL, Pierce C, Monteagudo C, et al. UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell 2008; 19:1354-1365.
20. Carlisle PL, Kadosh D. Candida albicans Ume6, a filament-specific transcriptional regulator, directs hyphal growth via a pathway involving Hgc1 cyclinrelated protein. Eukaryotic Cell 2010; 9:1320-1328.
21. Bastidas RJ, Heitman J, Cardenas ME. The Protein kinase Tor1 regulates adhesin gene expression in Candida albicans. PLoS Pathog 2009; 5:e1000294.
22. Rohde JR, Bastidas R, Puria R, Cardenas ME. Nutritional control via Tor signaling in Saccharomyces cerevisiae. Curr Opin Microbiol 2008; 11:153-160.
23. Zacchi LF, Gomez-Raja J, Davis DA. Mds3 regulates morphogenesis in Candida albicans through the TOR pathway. Mol Cell Biol 2010; 30:3695-3710.
24. Davis DA, Bruno VM, Loza L, Filler SG, Mitchell AP. Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 2002; 162:1573-1581.
25. Benni ML, Neigeborn L. Identification of a new class of negative regulators affecting sporulation-specific gene expression in yeast. Genetics 1997; 147:1351-1366.
26. Rohde JR, Campbell S, Zurita-Martinez SA, Cutler NS, Ashe M, Cardenas ME. TOR controls transcriptional and translational programs via Sap-Sit4 protein phosphatase signaling effectors. Mol Cell Biol 2004; 24:8332-8341.
27. Tournu H, Tripathi G, Bertram G, Macaskill S, Mavor A, Walker L, et al. Global role of the protein kinase, Gcn2, in the human pathogen, Candida albicans. Eukaryotic Cell 2005; 4:1687-1696.